Written by
Bilal H
Bilal H Liv Hospital Content Team
Medically reviewed by

Related Doctors

Prof. MD. Alp Burak Çatakoğlu Liv Hospital Ulus Prof. MD. Alp Burak Çatakoğlu Cardiology Prof. MD. Enis Oğuz Liv Hospital Ulus Prof. MD. Enis Oğuz Cardiology Prof. MD. Gökhan Ertaş Liv Hospital Ulus Prof. MD. Gökhan Ertaş Cardiology Prof. MD. Kadriye Kılıçkesmez Liv Hospital Ulus Prof. MD. Kadriye Kılıçkesmez Cardiology Prof. MD. Yelda Tayyareci Liv Hospital Ulus Prof. MD. Yelda Tayyareci Cardiology Spec. MD. Barış Güven Liv Hospital Ulus Spec. MD. Barış Güven Cardiology Assoc. Prof. MD. Çiğdem İleri Doğan Liv Hospital Vadistanbul Assoc. Prof. MD. Çiğdem İleri Doğan Cardiology Prof. MD.  Batur Gönenç Kanar Liv Hospital Vadistanbul Prof. MD. Batur Gönenç Kanar Cardiology Prof. MD. Mehmet Vefik Yazıcıoğlu Liv Hospital Vadistanbul Prof. MD. Mehmet Vefik Yazıcıoğlu Cardiology Spec. MD. Utku Zor Liv Hospital Vadistanbul Spec. MD. Utku Zor Cardiology Assoc. Prof. MD.  Ahmet Anıl Şahin Liv Hospital Bahçeşehir Assoc. Prof. MD. Ahmet Anıl Şahin Cardiology Prof. MD. Hasan Turhan Liv Hospital Bahçeşehir Prof. MD. Hasan Turhan Cardiology Spec. MD. Ali Yıldırım Liv Hospital Bahçeşehir Spec. MD. Ali Yıldırım Pediatric Cardiology Spec. MD. Selim Yazıcı Liv Hospital Bahçeşehir Spec. MD. Selim Yazıcı Cardiology Assoc. Prof. MD. Sinem Özbay Özyılmaz Liv Hospital Topkapı Assoc. Prof. MD. Sinem Özbay Özyılmaz Cardiology Asst. Prof. MD. Enes Alıç Liv Hospital Topkapı Asst. Prof. MD. Enes Alıç Cardiology Prof. MD. Hakan Uçar Liv Hospital Topkapı Prof. MD. Hakan Uçar Cardiology Prof. MD. Murat Sünbül Liv Hospital Topkapı Prof. MD. Murat Sünbül Cardiology Prof. MD. Mustafa Kürşat Tigen Liv Hospital Topkapı Prof. MD. Mustafa Kürşat Tigen Cardiology Liv Hospital Topkapı Prof. MD. Tolga Aksu Cardiology Assoc. Prof. MD. Alper Canbay Liv Hospital Ankara Assoc. Prof. MD. Alper Canbay Cardiology Assoc. Prof. MD. Sezen Bağlan Uzunget Liv Hospital Ankara Assoc. Prof. MD. Sezen Bağlan Uzunget Cardiology Asst. Prof. MD. Savaş Açıkgöz Liv Hospital Ankara Asst. Prof. MD. Savaş Açıkgöz Cardiology Prof. MD. Aytun Çanga Liv Hospital Ankara Prof. MD. Aytun Çanga Cardiology Prof. MD. Murat Tulmaç Liv Hospital Ankara Prof. MD. Murat Tulmaç Cardiology Spec. MD. Onur Yıldırım Liv Hospital Ankara Spec. MD. Onur Yıldırım Cardiology Prof. MD. Selim Topcu Liv Hospital Gaziantep Prof. MD. Selim Topcu Cardiology Spec. MD. Mehmet Boyunsuz Liv Hospital Gaziantep Spec. MD. Mehmet Boyunsuz Cardiology Asst. Prof. MD. Yunus Amasyalı Liv Hospital Samsun Asst. Prof. MD. Yunus Amasyalı Cardiology Spec. MD. Baran Yüksekkaya Liv Hospital Samsun Spec. MD. Baran Yüksekkaya Cardiology Assoc. Prof. MD. Mahmut Özdemir Assoc. Prof. MD. Mahmut Özdemir Cardiology Asst. Prof. MD. Kıvanç Eren Asst. Prof. MD. Kıvanç Eren Cardiology Spec. MD. Perviz Caferov Cardiology Assoc. Prof. MD. Meki Bilici Liv Hospital Ulus + Liv Hospital Vadistanbul Assoc. Prof. MD. Meki Bilici Pediatric Cardiology
...
Views
Read Time
...
views
Read Time
TAVR Success Rate: Inspiring Stats For Patients
TAVR Success Rate: Inspiring Stats For Patients 4

Transcatheter aortic valve replacement (TAVR) has changed how we treat aortic valve disease. It offers a minimally invasive alternative to open-heart surgery. Studies have found that TAVR can lower death rates and improve life quality more than just medicine.

Explore the TAVR success rate and discover inspiring statistics. Understand the risks and benefits of this life-saving heart procedure.

Even with its benefits, TAVR comes with risks. It’s important for patients and doctors to know these risks. This knowledge helps in making better choices.

Key Takeaways

  • TAVR is a minimally invasive procedure that replaces a narrowed aortic valve.
  • Recent studies have shown significant reductions in mortality with TAVR.
  • TAVR improves quality of life compared to medical therapy alone.
  • Understanding TAVR risks is key for making informed decisions.
  • TAVR is a good option instead of traditional open-heart surgery.

Understanding TAVR: A Minimally Invasive Heart Valve Replacement

Understanding TAVR: A Minimally Invasive Heart Valve Replacement
TAVR Success Rate: Inspiring Stats For Patients 5

For those with severe aortic stenosis, TAVR is a less invasive choice. Aortic stenosis makes the aortic valve narrow, blocking blood flow. TAVR is a key treatment for this issue.

What is Transcatheter Aortic Valve Replacement?

TAVR involves putting a new valve through a thin tube into the heart. This new valve replaces the old one, improving blood flow and easing symptoms.

How TAVR Differs from Traditional Open-Heart Surgery

TAVR is different from open-heart surgery. It uses smaller cuts and doesn’t need a heart-lung machine. This means less damage, faster recovery, and fewer risks.

Who Qualifies for TAVR Procedures

TAVR is for those with severe aortic stenosis at high risk for surgery. Doctors decide based on health, stenosis severity, and other factors.

Characteristics

TAVR

Open-Heart Surgery

Incision Size

Small

Large

Recovery Time

Typically shorter

Typically longer

Risk Profile

Lower for some patients

Higher for some patients

Knowing about TAVR helps patients choose the best treatment for them.

Short-Term Mortality Risk After TAVR

Short-Term Mortality Risk After TAVR
TAVR Success Rate: Inspiring Stats For Patients 6

The risk of death soon after Transcatheter Aortic Valve Replacement (TAVR) is a big worry for patients and doctors. This risk changes based on the patient’s health, how well the procedure goes, and the doctor’s skill.

30-Day Mortality Statistics

Research shows that the chance of dying within 30 days after TAVR has gone down. Rates range from 0.5% to 8%. This change is due to different patients and how the procedure is done.

Risk Factors for Early Mortality

Early death risks include patient comorbidities like kidney failure and COPD. Also, procedural complications like blood vessel damage and stroke play a big role.

Comparison Across Different Patient Populations

Looking at different groups of patients shows that those at higher risk, like older people or those with many health problems, face higher death rates within 30 days.

Patient Population

30-Day Mortality Rate

Low-Risk Patients

0.5% – 2%

High-Risk Patients

4% – 8%

In-Hospital Death Rates

In-hospital death rates after TAVR are key. They show the risks of the procedure during the first hospital stay.

Procedural Mortality Factors

Factors that affect death risk during the procedure include operator experience and device-related complications. Places that do more procedures tend to have lower death rates.

Long-Term Survival Rates for TAVR Patients

It’s important to know how well patients do long-term after Transcatheter Aortic Valve Replacement (TAVR). TAVR is a good choice for those at high risk or who can’t have open-heart surgery.

1-Year Survival Statistics

Research shows that 80% to 90% of patients live for a year after TAVR. This is a good sign, showing the procedure works well in the short term. How well it does depends on who gets it, how it’s done, and aftercare.

5-Year Mortality Data

But, survival rates drop over time. By five years, some studies say only 40% of patients might be alive. Age and health problems play big roles in survival chances.

Comparing Survival Rates Across Age Groups

Survival chances after TAVR differ a lot by age.

Elderly Patients (80+)

Elderly patients, with many health issues, tend to have lower 1-year survival rates. Yet, TAVR is a good option because it’s less invasive.

Younger Patients with Comorbidities

Younger patients with health problems face their own set of challenges. They might live longer than the elderly, but health issues can make recovery harder.

The success of TAVR depends on many things, like who gets it and how well it’s done. As TAVR gets better, so will survival rates.

“The success of TAVR is not just about the procedure itself, but also about the care patients get before, during, and after.”

— Expert in Cardiovascular Medicine

Knowing the TAVR success rate and long-term survival helps doctors and patients make better choices.

TAVR Success Rate: How Effective is the Procedure?

Looking at TAVR success means checking both how well the procedure works and how it improves life quality. TAVR’s success is not just about the procedure’s success. It’s also about how it affects patients’ lives.

Defining Success in TAVR Procedures

Success in TAVR is about a few key things. It’s when the valve is put in right, there are no big problems during the procedure, and patients feel better and can do more.

Procedural Success Statistics

Research shows TAVR works well, with success rates over 95% in most studies. These numbers show how skilled doctors are at doing TAVR.

Quality of Life Improvements

TAVR makes life better for people with severe aortic stenosis. It helps them feel better and do more things.

Functional Capacity Gains

After TAVR, patients can do more, like walking longer distances. This makes everyday tasks easier for them.

Symptom Relief Metrics

TAVR also makes symptoms like breathing hard and chest pain better. Feeling better overall is a big win for patients.

In short, TAVR is very successful, bringing big benefits in how well the procedure works and how life improves. Knowing this helps us see how good TAVR is as a treatment.

Risks of TAVR Procedure: Understanding the Complications

The risks of TAVR procedures are complex and need careful thought. TAVR is a less invasive option compared to open-heart surgery. Yet, it comes with its own set of complications.

Procedural Risks During TAVR

Several risks can happen during a TAVR procedure, including:

  • Access site complications, such as bleeding or vascular damage.
  • Valve deployment issues, which can lead to improper valve positioning or function.

Access Site Complications

Access site complications can happen because of how the procedure accesses the heart. Careful planning and execution are key to reducing these risks.

Valve Deployment Issues

Valve deployment issues can occur if the valve is not correctly placed or if there are problems during deployment. Advanced imaging techniques help lessen these risks.

Immediate Post-Procedural Risks

Right after the TAVR procedure, patients face risks like stroke, heart rhythm problems, and kidney injury. Close monitoring is vital to spot and handle these risks quickly.

Risk Mitigation Strategies

To lower TAVR risks, healthcare providers use several methods. These include choosing patients carefully, using precise procedural techniques, and providing detailed post-procedure care.

Understanding TAVR’s complications and using strategies to reduce them helps healthcare providers improve patient outcomes.

Common Complications That Affect TAVR Mortality

The TAVR procedure is less invasive but comes with risks that can affect how long a patient lives. It’s important to know these risks to help patients understand what to expect.

Vascular Complications

Vascular issues are a big worry with TAVR. These can include bleeding, hematoma, and vascular dissection. Choosing the right patient and being very careful during the procedure helps lower these risks.

Stroke Risk

Stroke is a possible side effect of TAVR, caused by the movement of catheters in the aorta. Embolic protection devices are being made to reduce this risk.

Paravalvular Leak

Paravalvular leak (PVL) is another issue that can happen after TAVR. It can cause serious problems and even death if not treated. Getting the valve size and position right is key to avoiding PVL.

Heart Block and Pacemaker Requirements

Heart block is a known side effect of TAVR, sometimes needing a pacemaker. The risk of heart block depends on the patient’s heart health before the procedure and how deep the valve is implanted.

These complications show why it’s so important to carefully choose patients, do the procedure well, and take good care of them after. By understanding and tackling these risks, doctors can make sure patients do better.

Risk Factors That Increase TAVR Mortality

Several key factors can increase the risk of mortality after undergoing a Transcatheter Aortic Valve Replacement (TAVR) procedure. Understanding these risk factors is essential for optimizing patient outcomes.

Age-Related Risk Factors

Advanced age is a significant risk factor for mortality after TAVR. Older patients often have more comorbidities and reduced physiological reserve, making them more susceptible to procedural complications.

Pre-existing Medical Conditions

Pre-existing medical conditions play a critical role in determining TAVR outcomes. Conditions such as kidney disease, pulmonary hypertension, and coronary artery disease can complicate the procedure and post-operative recovery.

Kidney Disease

Patients with chronic kidney disease or those on dialysis are at higher risk of complications and mortality after TAVR. Kidney disease can affect the body’s ability to recover from the procedure.

Pulmonary Hypertension

Pulmonary hypertension can increase the risk of mortality by complicating anesthesia management and post-operative care. Careful assessment and management are critical.

Coronary Artery Disease

The presence of coronary artery disease can complicate TAVR by increasing the risk of procedural complications and affecting long-term survival.

Frailty and Functional Status

Frailty and poor functional status are associated with higher mortality rates after TAVR. Assessing frailty can help identify patients who may benefit from prehabilitation or alternative treatments.

Anatomical Considerations

Anatomical factors, including the size and shape of the aortic valve annulus, can affect the success of TAVR. Careful planning and the use of appropriate imaging techniques are essential.

By understanding and addressing these risk factors, healthcare providers can improve patient selection, optimize procedural techniques, and enhance post-operative care. This can ultimately reduce TAVR mortality rates.

TAVR vs. SAVR: Comparing Mortality Risks

Choosing between TAVR and SAVR means understanding their different risks. Both treat aortic valve disease well, but their risks depend on various factors.

Surgical Aortic Valve Replacement Risk Profile

SAVR is a long-standing open-heart surgery. It’s effective but comes with risks of open-heart surgery, including death. The risk for SAVR depends on the patient’s age, health, and other medical conditions.

Head-to-Head Mortality Comparisons

Research has looked at TAVR and SAVR’s mortality risks. A study found TAVR might have a lower mortality risk than SAVR for some patients. But, results can differ based on patient specifics and the procedure.

Which Patients Benefit Most from TAVR vs. SAVR

Patients at high or intermediate risk for surgery usually do better with TAVR. It’s less invasive. Younger patients or those at lower risk might prefer SAVR for its durability. The choice between TAVR and SAVR depends on the patient’s unique situation and preferences.

How Risk Assessment Tools Predict TAVR Outcomes

Risk assessment tools are key in predicting how well patients will do with Transcatheter Aortic Valve Replacement (TAVR). They help doctors find out who might face more risks. This helps them decide if TAVR is the right choice for each patient.

STS Score and TAVR Risk Prediction

The Society of Thoracic Surgeons (STS) score is a well-known tool. It predicts the risk of death after heart surgery, like TAVR. It looks at things like age, health problems, and heart function to guess the risk of complications.

EuroSCORE II for TAVR Patients

The EuroSCORE II is another tool used for TAVR patients. It estimates the risk of death after heart surgery based on different health factors. Both STS score and EuroSCORE II are helpful, but they’re not perfect for predicting TAVR results.

Limitations of Current Risk Models

Current models, like STS score and EuroSCORE II, have their downsides. They were made for a different kind of heart surgery. They might not fully understand the unique challenges of TAVR.

Emerging Risk Assessment Approaches

New ways to assess risk, like machine learning, are being looked into. These methods might be better at understanding each patient’s risk. They could offer more accurate predictions for TAVR.

Key Takeaways:

  • Risk assessment tools are vital for predicting TAVR outcomes.
  • STS score and EuroSCORE II are common risk models.
  • New approaches are being explored to improve risk prediction.

Post-TAVR Recovery and Associated Risks

Recovery after TAVR is a key phase that needs close watch and care. Even after the procedure, TAVR procedure risks can persist. Some complications may show up during the recovery time.

Immediate Post-Procedure Risks

Right after TAVR, patients face risks of bleeding and vascular issues. These problems can stem from the site used for the procedure. A study in a top medical journal found that vascular issues are a big worry after TAVR. They can harm patient outcomes.

“Vascular complications are a major contributor to morbidity and mortality after TAVR.”

Hospital Stay Duration and Complications

The time spent in the hospital after TAVR can vary. Complications during this time can affect recovery. Issues like paravalvular leak and heart block might need extra treatments.

Long-term Recovery Challenges

Long-term, TAVR patients must deal with managing transcatheter aortic valve replacement complications. They also need to make sure the valve lasts. Regular check-ups are key to watching these aspects and fixing any problems quickly.

Evolution of TAVR Outcomes Over Time

Transcatheter Aortic Valve Replacement (TAVR) has seen big changes over the years. Better devices, more skilled doctors, and new ways of doing things have all helped. These changes have made TAVR better for patients.

First-Generation vs. Current-Generation Devices

Going from old to new TAVR devices has made a big difference. The latest devices aim to cut down on problems and help patients heal faster.

Improving Operator Experience and Outcomes

Doctors getting better at TAVR has led to better results. This is key to making TAVR a success.

Institutional Volume and Mortality Correlation

How many TAVR procedures a place does affects how well patients do. Places that do a lot of these procedures tend to do better.

High-Volume Centers vs. Low-Volume Centers

Places that do a lot of TAVR have fewer deaths and problems. This is because they have more experience and better plans.

Learning Curve Effects on Patient Mortality

Getting better at TAVR lowers the risk of death. As everyone gets more practice, the risk goes down.

Institution Type

Mortality Rate

Complication Rate

High-Volume Centers

2%

5%

Low-Volume Centers

5%

10%

The story of TAVR shows us how important it is to keep getting better. With new devices, more training, and better plans, TAVR will keep getting better. This means better results for those who need it.

Conclusion: Weighing the Risks and Benefits of TAVR

Transcatheter Aortic Valve Replacement (TAVR) is a key treatment for severe aortic stenosis. It brings relief from symptoms and improves quality of life. It’s important to know the tavr risk and risks of tavr to see if it’s right for each patient.

The transcatheter aortic valve replacement risks include procedural and long-term mortality risks. There are also possible complications. But, the tavr success rate is high, leading to better lives for many patients.

It’s vital to carefully consider the risks and benefits of TAVR. This ensures patients get the best treatment for their needs. Healthcare providers use the latest data and patient factors to make these decisions.

FAQ

What is Transcatheter Aortic Valve Replacement (TAVR) and how does it differ from traditional open-heart surgery?

TAVR is a new way to replace the aortic valve without a big cut in the chest. It’s different from open-heart surgery because it uses a small incision, usually in the leg, to reach the heart.

What are the risks associated with TAVR?

TAVR can have risks like bleeding, stroke, and heart problems. These risks happen during the procedure or right after.

What is the mortality risk for TAVR patients?

The risk of dying after TAVR depends on several things. These include how old you are, any health problems you have, and how strong you are. The risk of dying in the first 30 days or while in the hospital is also a concern.

How effective is TAVR in improving quality of life?

TAVR greatly improves life quality and ability to do daily activities for people with severe aortic stenosis. It helps them get back to their normal life.

What are the long-term survival rates for TAVR patients?

Long-term survival after TAVR varies. Data shows survival rates at 1 year and 5 years. Survival depends on age, health conditions, and how well the procedure goes.

How does TAVR compare to Surgical Aortic Valve Replacement (SAVR) in terms of mortality risks?

TAVR and SAVR have different risks. TAVR is often safer for those at high risk for surgery. Studies show different death rates for each treatment.

What role do risk assessment tools play in predicting TAVR outcomes?

Tools like the STS score and EuroSCORE II help predict TAVR results. They look at patient risk factors. But, these tools have limits, and new ways to assess risk are being developed.

What are the common complications that can affect TAVR mortality?

Complications like bleeding, stroke, and heart problems can raise TAVR death risk. These issues can affect how well a patient does and how long they live.

How has TAVR evolved over time, and what impact has this had on patient outcomes?

TAVR has changed a lot over time. Better devices, more experience, and more procedures have all helped improve results. This has led to better survival rates and quality of life for patients.

What is the success rate of TAVR procedures?

TAVR success rates are high. Patients see big improvements in their health and life quality. Success is measured by how well the procedure works and how long patients live.

What are the risk factors that increase TAVR mortality?

Older age, health problems, frailty, and certain heart shapes are risk factors for TAVR death. Knowing these helps predict how well a patient will do.

Reference

New England Journal of Medicine. Evidence-Based Medical Insight. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMoa1103512

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Prof. MD. Alp Burak Çatakoğlu Liv Hospital Ulus Prof. MD. Alp Burak Çatakoğlu Cardiology Prof. MD. Enis Oğuz Liv Hospital Ulus Prof. MD. Enis Oğuz Cardiology Prof. MD. Gökhan Ertaş Liv Hospital Ulus Prof. MD. Gökhan Ertaş Cardiology Prof. MD. Kadriye Kılıçkesmez Liv Hospital Ulus Prof. MD. Kadriye Kılıçkesmez Cardiology Prof. MD. Yelda Tayyareci Liv Hospital Ulus Prof. MD. Yelda Tayyareci Cardiology Spec. MD. Barış Güven Liv Hospital Ulus Spec. MD. Barış Güven Cardiology Assoc. Prof. MD. Çiğdem İleri Doğan Liv Hospital Vadistanbul Assoc. Prof. MD. Çiğdem İleri Doğan Cardiology Prof. MD.  Batur Gönenç Kanar Liv Hospital Vadistanbul Prof. MD. Batur Gönenç Kanar Cardiology Prof. MD. Mehmet Vefik Yazıcıoğlu Liv Hospital Vadistanbul Prof. MD. Mehmet Vefik Yazıcıoğlu Cardiology Spec. MD. Utku Zor Liv Hospital Vadistanbul Spec. MD. Utku Zor Cardiology Assoc. Prof. MD.  Ahmet Anıl Şahin Liv Hospital Bahçeşehir Assoc. Prof. MD. Ahmet Anıl Şahin Cardiology Prof. MD. Hasan Turhan Liv Hospital Bahçeşehir Prof. MD. Hasan Turhan Cardiology Spec. MD. Ali Yıldırım Liv Hospital Bahçeşehir Spec. MD. Ali Yıldırım Pediatric Cardiology Spec. MD. Selim Yazıcı Liv Hospital Bahçeşehir Spec. MD. Selim Yazıcı Cardiology Assoc. Prof. MD. Sinem Özbay Özyılmaz Liv Hospital Topkapı Assoc. Prof. MD. Sinem Özbay Özyılmaz Cardiology Asst. Prof. MD. Enes Alıç Liv Hospital Topkapı Asst. Prof. MD. Enes Alıç Cardiology Prof. MD. Hakan Uçar Liv Hospital Topkapı Prof. MD. Hakan Uçar Cardiology Prof. MD. Murat Sünbül Liv Hospital Topkapı Prof. MD. Murat Sünbül Cardiology Prof. MD. Mustafa Kürşat Tigen Liv Hospital Topkapı Prof. MD. Mustafa Kürşat Tigen Cardiology Liv Hospital Topkapı Prof. MD. Tolga Aksu Cardiology Assoc. Prof. MD. Alper Canbay Liv Hospital Ankara Assoc. Prof. MD. Alper Canbay Cardiology Assoc. Prof. MD. Sezen Bağlan Uzunget Liv Hospital Ankara Assoc. Prof. MD. Sezen Bağlan Uzunget Cardiology Asst. Prof. MD. Savaş Açıkgöz Liv Hospital Ankara Asst. Prof. MD. Savaş Açıkgöz Cardiology Prof. MD. Aytun Çanga Liv Hospital Ankara Prof. MD. Aytun Çanga Cardiology Prof. MD. Murat Tulmaç Liv Hospital Ankara Prof. MD. Murat Tulmaç Cardiology Spec. MD. Onur Yıldırım Liv Hospital Ankara Spec. MD. Onur Yıldırım Cardiology Prof. MD. Selim Topcu Liv Hospital Gaziantep Prof. MD. Selim Topcu Cardiology Spec. MD. Mehmet Boyunsuz Liv Hospital Gaziantep Spec. MD. Mehmet Boyunsuz Cardiology Asst. Prof. MD. Yunus Amasyalı Liv Hospital Samsun Asst. Prof. MD. Yunus Amasyalı Cardiology Spec. MD. Baran Yüksekkaya Liv Hospital Samsun Spec. MD. Baran Yüksekkaya Cardiology Assoc. Prof. MD. Mahmut Özdemir Assoc. Prof. MD. Mahmut Özdemir Cardiology Asst. Prof. MD. Kıvanç Eren Asst. Prof. MD. Kıvanç Eren Cardiology Spec. MD. Perviz Caferov Cardiology Assoc. Prof. MD. Meki Bilici Liv Hospital Ulus + Liv Hospital Vadistanbul Assoc. Prof. MD. Meki Bilici Pediatric Cardiology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Meki Bilici Pediatric Cardiology

Assoc. Prof. MD. Meki Bilici

Liv Hospital Ulus
Liv Hospital Vadistanbul
Prof. MD. Alp Burak Çatakoğlu Cardiology

Prof. MD. Alp Burak Çatakoğlu

Liv Hospital Ulus
Prof. MD. Enis Oğuz Cardiology

Prof. MD. Enis Oğuz

Liv Hospital Ulus
Prof. MD. Gökhan Ertaş Cardiology

Prof. MD. Gökhan Ertaş

Liv Hospital Ulus
Prof. MD. Kadriye Kılıçkesmez Cardiology

Prof. MD. Kadriye Kılıçkesmez

Liv Hospital Ulus
Prof. MD. Yelda Tayyareci Cardiology

Prof. MD. Yelda Tayyareci

Liv Hospital Ulus
Spec. MD. Barış Güven Cardiology

Spec. MD. Barış Güven

Liv Hospital Ulus
Assoc. Prof. MD. Çiğdem İleri Doğan Cardiology

Assoc. Prof. MD. Çiğdem İleri Doğan

Liv Hospital Vadistanbul
Prof. MD.  Batur Gönenç Kanar Cardiology

Prof. MD. Batur Gönenç Kanar

Liv Hospital Vadistanbul
Prof. MD. Mehmet Vefik Yazıcıoğlu Cardiology

Prof. MD. Mehmet Vefik Yazıcıoğlu

Liv Hospital Vadistanbul
Spec. MD. Utku Zor Cardiology

Spec. MD. Utku Zor

Liv Hospital Vadistanbul
Assoc. Prof. MD.  Ahmet Anıl Şahin Cardiology

Assoc. Prof. MD. Ahmet Anıl Şahin

Liv Hospital Bahçeşehir
Prof. MD. Hasan Turhan Cardiology

Prof. MD. Hasan Turhan

Liv Hospital Bahçeşehir
Spec. MD. Ali Yıldırım Pediatric Cardiology

Spec. MD. Ali Yıldırım

Liv Hospital Bahçeşehir
Spec. MD. Selim Yazıcı Cardiology

Spec. MD. Selim Yazıcı

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Sinem Özbay Özyılmaz Cardiology

Assoc. Prof. MD. Sinem Özbay Özyılmaz

Liv Hospital Topkapı
Asst. Prof. MD. Enes Alıç Cardiology

Asst. Prof. MD. Enes Alıç

Liv Hospital Topkapı
Prof. MD. Hakan Uçar Cardiology

Prof. MD. Hakan Uçar

Liv Hospital Topkapı
Prof. MD. Murat Sünbül Cardiology

Prof. MD. Murat Sünbül

Liv Hospital Topkapı
Prof. MD. Mustafa Kürşat Tigen Cardiology

Prof. MD. Mustafa Kürşat Tigen

Liv Hospital Topkapı
Cardiology

Prof. MD. Tolga Aksu

Liv Hospital Topkapı
Assoc. Prof. MD. Alper Canbay Cardiology

Assoc. Prof. MD. Alper Canbay

Liv Hospital Ankara
Assoc. Prof. MD. Sezen Bağlan Uzunget Cardiology

Assoc. Prof. MD. Sezen Bağlan Uzunget

Liv Hospital Ankara
Asst. Prof. MD. Savaş Açıkgöz Cardiology

Asst. Prof. MD. Savaş Açıkgöz

Liv Hospital Ankara
Prof. MD. Aytun Çanga Cardiology

Prof. MD. Aytun Çanga

Liv Hospital Ankara
Prof. MD. Murat Tulmaç Cardiology

Prof. MD. Murat Tulmaç

Liv Hospital Ankara
Spec. MD. Onur Yıldırım Cardiology

Spec. MD. Onur Yıldırım

Liv Hospital Ankara
Prof. MD. Selim Topcu Cardiology

Prof. MD. Selim Topcu

Liv Hospital Gaziantep
Spec. MD. Mehmet Boyunsuz Cardiology

Spec. MD. Mehmet Boyunsuz

Liv Hospital Gaziantep
Asst. Prof. MD. Yunus Amasyalı Cardiology

Asst. Prof. MD. Yunus Amasyalı

Liv Hospital Samsun
Spec. MD. Baran Yüksekkaya Cardiology

Spec. MD. Baran Yüksekkaya

Liv Hospital Samsun
Assoc. Prof. MD. Mahmut Özdemir Cardiology

Assoc. Prof. MD. Mahmut Özdemir

Asst. Prof. MD. Kıvanç Eren Cardiology

Asst. Prof. MD. Kıvanç Eren

Cardiology

Spec. MD. Perviz Caferov

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91